← Leaderboards
Raja Mudad
Tulane University Of Louisiana
$10,986
Attributed
$10,986
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.5K · FY2005–06$10K$7.5K$5K$2.5K$0
'05
'06
Funding mix
By agency
NIH$10,986 · 4
By mechanism
M01$10,986 · 4
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Juan J. L. Lertora$4,837,795
- Russell Barrett Van Dyke$24,377,705
- William McKinnon$49,515
- Eugene A Woltering$73,643
- Newton E Hyslop$54,429
Others in their field
Top investigators on “Nonsmall Cell Lung Cancer”
- Charles A Coltman · Southwest Oncology Group$18,209,974
- David Sidransky · Johns Hopkins University$16,110,661
- Tyler E Jacks · Massachusetts Institute Of Technology$4,787,518
- Bonnie Ky · University Of Pennsylvania$3,706,294
- Roman Perez-Soler · New York University School Of Medicine$3,465,243
- David A Boothman · Case Western Reserve University$3,430,892
Research focus
Nonsmall Cell Lung CancerPaclitaxelClinical ResearchClinical Trial Phase ICombination Cancer TherapyCombination ChemotherapyNeoplasm /Cancer ChemotherapyNeoplasm /Cancer Radiation TherapyHuman SubjectHuman Therapy EvaluationDosageCis Platinum CompoundPatient Oriented ResearchDrug Screening /EvaluationCisplatin
Grant awards (5)
CONCURRENT CHEMOTHERAPY + CETUXIMAB VS CHEMOTHERAPY IN ADVANCED NSCLC$1,166
M01 · FY2006 · RR · contact PI
STUDY OF ARSENIC TRIOXIDE IN COMBINATION WITH 5-FU IN GASTROINTESTINAL TUMORS$9,466
M01 · FY2005 · RR
RM 98-1: Combined Modality Therapy For Locally Advanced Non-Small Cell Lung Ca$354
M01 · FY2004 · RR
CISPLATIN, DOCETAXEL, RADIATION THERAPY FOR NSCLC$0
M01 · FY2001 · RR
CISPLATIN, DOCETAXEL, RADIATION THERAPY FOR NSCLC$0
M01 · FY2000 · RR